No Data
Is iFlytek planning to lay out smart driving? Li Zhanmei: There will be cars that will be mass-produced gradually this year.
The China Electric Vehicle 100 People Forum (2025) will be held from March 28 to March 30 in Peking, with the theme "Consolidating Electrification, Promoting Intelligentization, and Achieving High-Quality Development." The Senior Vice President of Iflytek Co.,ltd. Smart Automobile Business, Li Zhanmei, shared the progress of Iflytek in the field of intelligent driving. He stated that Iflytek is also making plans for intelligent driving, and currently, Iflytek's business in the automobile Sector is divided into four parts: the first part is smart cockpit, the second part is intelligent sound field, the third part is intelligent driving, and the fourth part is enterprise digitalization. In addition, he also mentioned that intelligent driving will be a crucial part of Iflytek's automobile business, because we are currently.
Big models getting caught up in competition? Li Zhanmei: End users will definitely vote with their feet, it won't be through a price war.
The China Electric Vehicle Hundred People's Forum (2025) will be held in Peking from March 28 to March 30, with the theme "Consolidating Electrification, Promoting Intelligentization, Achieving High-Quality Development." Li Zhanmei, Senior Vice President of Smart Automobile Business at Iflytek Co.,ltd., mentioned that as model technology comes into more applications, especially as end-users perceive the value brought by large models, the business model will become increasingly evident. He pointed out that in the past year, including Iflytek and other competitors, to be honest, have been pouring money into it, and some competitors have even offered funding for certain projects.
Zhuhai International: Initiates a Buy rating on iFlytek Medical Technology with a Target Price of HKD 170.56.
Zhaoyin International released a Research Report stating that it initiates coverage on Xunfei Medical Technology (02506) with a "Buy" rating. Based on the average P/S of comparable companies, a 13 times P/S for 2026 is given to reflect the bank's Bullish outlook on the company's high growth potential, with a Target Price of 170.56 HKD. The bank is optimistic about the application prospects of medical AI, noting that Xunfei Medical has a first-mover advantage and solid technological barriers in the medical AI field, and expects the company's revenue compound growth rate from 2023 to 2026 to reach 36.9%. Zhaoyin International's main viewpoints are as follows: Xunfei Medical is a leading player in China's medical AI sector, relying on the Xinghuo Medical large model to empower.
[In-depth Industry Research] Is Iflytek Co.,ltd. the hidden giant behind the Autos Industry?
Author | Yuan Fang Zheng Wen, a total of 3409 words, estimated reading time 10 minutes. Recently, Iflytek Co.,ltd. and BAIC Group officially signed a framework agreement for Global Strategy cooperation, and both parties will carry out all-round collaboration in the field of autos intelligence. In fact, Iflytek Co.,ltd. has been deeply engaged in the field of autos intelligence for many years, with its cooperation scope covering over 90% of automotive companies, from domestic independent car makers to joint venture brands, from traditional RBOB Gasoline giants to new forces in the New energy Fund, Iflytek Co.,ltd.'s presence can almost be seen everywhere, including FAW, Changan, Dongfeng, SAIC, GAC, Chery, Great Wall, BYD, Geely, NIO, Leap Motor, ZEEKR, Volkswagen, and Nissan.
IFLYTEKLTD (SZSE:002230) Shareholders Have Earned a 7.5% CAGR Over the Last Five Years
Iflytek Co.,ltd. collaborates with Huawei! They are the first to achieve large-scale cross-node expert parallel cluster inference using domestic computing power.
On March 11th, Sina Technology reported that recently, Iflytek Co., Ltd. and Huawei have made significant progress in the domestic computing power field. The joint team was the first to break through the large-scale cross-node expert parallel inference of the MoE model on domestic computing power clusters. This is the industry's first new solution based on domestic computing power following DeepSeek's announcement of its MoE model training and inference scheme. The team completed verification and deployment on the Ascend cluster by deeply exploring the potential of hardware through deep cooperation and innovation in both software and hardware across multiple key technological levels. In terms of operator fusion, the team used Vector during the MLA preprocessing stage.
